scholarly article | Q13442814 |
P356 | DOI | 10.1001/ARCHOPHT.1990.01070080058036 |
P698 | PubMed publication ID | 1693496 |
P433 | issue | 6 | |
P921 | main subject | light coagulation | Q73523884 |
krypton | Q888 | ||
laser | Q38867 | ||
P304 | page(s) | 816-824 | |
P577 | publication date | 1990-06-01 | |
P1433 | published in | JAMA Ophthalmology | Q4787301 |
P1476 | title | Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group | |
P478 | volume | 108 |
Q30912261 | A pilot study of ICG-guided laser photocoagulation for occult choroidal neovascularization presenting as a focal spot in age-related macular degeneration |
Q71692991 | Age-related macular degeneration after extracapsular cataract extraction with intraocular lens implantation |
Q36696019 | Age-related macular degeneration and choroidal neovascularization. |
Q33263472 | Age-related macular degeneration--emerging pathogenetic and therapeutic concepts |
Q32004815 | Age-related macular degeneration: a review of experimental treatments |
Q38178644 | Age-related macular degeneration: beyond anti-angiogenesis |
Q30666801 | Age-related macular degeneration: cost-of-illness issues |
Q31048292 | Age-related macular degeneration: epidemiology and optimal treatment |
Q30749075 | Angiographic pattern of recurrent choroidal neovascularization in age-related macular degeneration |
Q44443130 | Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration |
Q36830200 | Assessment of visual function in choroidal neovascularization with scanning laser microperimetry and simultaneous indocyanine green angiography |
Q73211609 | Choroidal neovascularization in second eyes of patients with unilateral exudative age-related macular degeneration |
Q67464768 | Clinical Evaluation of Indocyanine Green Video-Angiography in the Diagnosis of Choroidal Neovascular Membrane Associated with Age-Related Macular Degeneration |
Q33227800 | Clinical experience with the surgical removal of subfoveal neovascular membranes. Short-term postoperative results |
Q30699719 | Clinical significance of postlaser indocyanine green angiographic hot spots in age-related macular degeneration |
Q33460962 | Combined intravitreal anti-VEGF and verteporfin photodynamic therapy for juxtafoveal and extrafoveal choroidal neovascularization as an alternative to laser photocoagulation |
Q48304782 | Comparison of serum thiol-disulphide homeostasis and total antioxidant-oxidant levels between exudative age-related macular degeneration patients and healthy subjects |
Q35509833 | Complement, age-related macular degeneration and a vision of the future |
Q36838817 | Diode laser photocoagulation of choroidal neovascular membranes |
Q32118775 | Eligibility for treatment and angiographic features at the early stage of exudative age related macular degeneration |
Q30773162 | External beam radiotherapy for subretinal neovascularization in age-related macular degeneration: is this treatment efficient? |
Q30716823 | Fluorescein angiographic abnormalities after prophylactic macular photocoagulation for high-risk age-related maculopathy. |
Q36070331 | Hearing and visual impairments |
Q36673982 | Indocyanine green angiography and occult choroidal neovascularization |
Q36862075 | Indocyanine green hyperfluorescence associated with serous retinal pigment epithelial detachment in age-related macular degeneration |
Q24811544 | Intravitreal triamcinolone with transpupillary therapy for subfoveal choroidal neovascularization in age related macular degeneration. A randomized controlled pilot study [ISRCTN74123635]. |
Q36977415 | Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration |
Q36699430 | Laser energy and dye fluorescence transmission through blood in vitro |
Q30887038 | Laser eye injuries |
Q24247642 | Laser photocoagulation for choroidal neovascularisation in myopic macular degeneration |
Q24244141 | Laser photocoagulation for neovascular age-related macular degeneration |
Q24247594 | Laser photocoagulation for neovascular age-related macular degeneration |
Q36697469 | Laser treatment of choroidal neovascularization in patients with angioid streaks. |
Q36675477 | Long-term outcomes after the surgical removal of advanced subfoveal neovascular membranes in age-related macular degeneration. |
Q26767095 | Management of Neovascular Age-related Macular Degeneration: A Review on Landmark Randomized Controlled Trials |
Q30806788 | Methylprednisolone therapy for retinal laser injury |
Q50514148 | Near-infrared (NIR) laparoscopy for intraoperative lymphatic road-mapping and sentinel node identification during definitive surgical resection of early-stage colorectal neoplasia. |
Q35704053 | Neuroprotection in ophthalmology: a review |
Q35016867 | Optical coherence tomographic and visual results at six months after transitioning to aflibercept for patients on prior ranibizumab or bevacizumab treatment for exudative age-related macular degeneration (an American Ophthalmological Society thesis) |
Q36814558 | Optical coherence tomography of age-related macular degeneration and choroidal neovascularization |
Q36837327 | Phase I/II study of proton beam irradiation for the treatment of subfoveal choroidal neovascularization in age-related macular degeneration: treatment techniques and preliminary results |
Q32138422 | Phenotypic heterogeneity in families with age-related macular degeneration |
Q45239423 | Photodynamic therapy with verteporfin for choroidal neovascularisations in clinical routine outside the TAP study. One- and two-year results including juxtafoveal and extrafoveal CNV. |
Q44767170 | Photodynamic therapy. Foreword |
Q34416380 | Photosensitizer delivery for photodynamic therapy of choroidal neovascularization |
Q47361893 | Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration. |
Q26799548 | Polypoidal Choroidal Vasculopathy in Asians |
Q74071278 | Presumed macular choroidal watershed vascular filling, choroidal neovascularization, and systemic vascular disease in patients with age-related macular degeneration |
Q36800399 | Radiation therapy for subretinal neovascularization |
Q31933114 | Radiotherapy for age-related macular degeneration |
Q34534297 | Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1. |
Q30653873 | Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. |
Q33291179 | Retinal function and PKC alpha expression after focal laser photocoagulation |
Q72650582 | Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration? |
Q36831395 | Retinotomy and foveal translocation for surgical management of subfoveal choroidal neovascular membranes |
Q71701307 | Selective use of indocyanine green angiography for occult choroidal neovascularization |
Q74148616 | Strontium plaque irradiation of subfoveal neovascular membranes in age-related macular degeneration |
Q57099862 | Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: i. ophthalmic outcomes submacular surgery trials pilot study report nu |
Q57099876 | Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: ii. quality of life outcomes submacular surgery trials pilot study rep |
Q36696619 | Subretinal endophotocoagulation in the treatment of choroidal neovascularization. |
Q34081868 | Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11. |
Q30990180 | Surgical management of subfoveal choroidal neovascularization |
Q71686759 | Surgical removal of idiopathic, myopic and age-related subfoveal neovascularization |
Q34655539 | The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1. |
Q34651797 | The Age-Related Eye Disease Study: a clinical trial of zinc and antioxidants--Age-Related Eye Disease Study Report No. 2 |
Q36768587 | The Diagnostic Accuracy of Optical Coherence Tomography Angiography for Neovascular Age-Related Macular Degeneration: A Comparison with Fundus Fluorescein Angiography |
Q47183944 | The estimation of approximate sample size requirements necessary for clinical and epidemiological studies in vision sciences |
Q34161956 | The past, present, and future of exudative age-related macular degeneration treatment |
Q30883222 | The role of submacular surgery in the treatment of choroidal neovascular membranes |
Q46527056 | The treatment of choroidal neovascular membranes by alpha interferon. An efficacy and toxicity study |
Q74821681 | The use of corticosteroids for choroidal neovascularisation in young patients |
Q73939433 | Treatment of age-related macular degeneration |
Q33232109 | Ultrahigh resolution optical coherence tomography in non-exudative age related macular degeneration |
Q71640378 | Visual results after surgical removal of subfoveal choroidal neovascular membranes |
Search more.